Cardinal Health Inc  

(Public, NYSE:CAH)   Watch this stock  
Find more results for CAH
-0.05 (-0.06%)
After Hours: 82.20 0.00 (0.00%)
Mar 28, 4:38PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 81.61 - 82.29
52 week 62.70 - 87.85
Open 81.95
Vol / Avg. 1.41M/1.88M
Mkt cap 25.93B
P/E 19.78
Div/yield 0.45/2.18
EPS 4.16
Shares 315.45M
Beta 0.78
Inst. own 92%
Jan 30, 2017
Q2 2017 Cardinal Health Inc Earnings Release (Estimated)
Jan 9, 2017
Cardinal Health Inc at JPMorgan Healthcare Conference- Q&A
Jan 9, 2017
Cardinal Health Inc at JPMorgan Healthcare Conference
Jan 5, 2017
Cardinal Health Inc at Goldman Sachs CEOs Unplugged Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 0.98% 1.18%
Operating margin 1.63% 2.02%
EBITD margin - 2.61%
Return on average assets 3.74% 4.45%
Return on average equity 20.25% 22.28%
Employees 37,300 -
CDP Score - 85 D


7000 Cardinal Pl
DUBLIN, OH 43017-1091
United States - Map
+1-614-7573033 (Phone)
+1-614-7576000 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Officers and directors

George S. Barrett Chairman of the Board, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Michael C. Kaufmann Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
Donald M. Casey Jr. Chief Executive Officer - Medical Segment
Age: 56
Bio & Compensation  - Reuters
Jon L. Giacomin Chief Executive Officer - Pharmaceutical segment
Age: 51
Bio & Compensation  - Reuters
Pamela O. Kimmet Chief Human Resource Officer
Age: 58
Bio & Compensation  - Reuters
Patricia B. Morrison Executive Vice President - Customer Support Services and Chief Information Officer
Age: 57
Bio & Compensation  - Reuters
Craig S. Morford Chief Legal and Compliance Officer
Age: 57
Bio & Compensation  - Reuters
Gregory B. Kenny Lead Independent Director
Age: 63
Bio & Compensation  - Reuters
David John Anderson Independent Director
Age: 67
Bio & Compensation  - Reuters
Colleen F. Arnold Independent Director
Age: 59
Bio & Compensation  - Reuters